🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
The purpose of this expanded access program is to provide VX-770 prior to i...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01381289
Treatments Being Tested
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Status
Completed
Location
Telethon Kids Institute
Start Date
2021-01-11
Trial ID
NCT04545515
Treatments Being Tested
This will be a double-blind, randomized, placebo-controlled, parallel group...
Status
Completed
Location
University of Alabama
Start Date
2015-11
Trial ID
NCT02589236
Treatments Being Tested
To evaluate the effect of ciprofloxacin on the pharmacokinetics (PK) of iva...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02015507
Treatments Being Tested
The study is a Phase 2 Study to establish the safety and efficacy of a drug...
Status
Completed
Location
UAB Lung Health Center
Start Date
2017-03-16
Trial ID
NCT03085485
Treatments Being Tested
Clinical studies of lumacaftor + ivacaftor (combo therapy) produced better ...
Status
Completed
Location
Stanford Hospital and Clinics
Start Date
2015-07-31
Trial ID
NCT02310789
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
This is a prospective, single-center, fixed-sequence, nonrandomized, open-l...
Status
Completed
Location
University of Southern California
Start Date
2022-05-09
Trial ID
NCT04840862
Treatments Being Tested